2713-28-2

Basic information

• Product Name: 2-Fluoro-4-Iodophenol
• Synonyms: Phenol,2-fluoro-4-iodo-;4-Iodo-2-fluorophenol;2-Fluoro-4-Iodophenol;O-Fluoro-P-Iodophenol
• CAS NO: 2713-28-2
• Molecular Formula: C₆H₄FIO
• Molecular Weight: 237.9982332
• Mol File: 2713-28-2.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 238.1 °C at 760 mmHg
• Flash Point: 97.8 °C
• Appearance: /
• Density: 2.085 g/cm³
• Vapor Pressure: 0.028mmHg at 25°C
• Refractive Index: 1.638
• Storage Temp.: Keep in dark place,Sealed in dry,Store in freezer, under -20°C
• PKA: 8.10±0.18(Predicted)
• CAS DataBase Reference: 2-Fluoro-4-Iodophenol(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Fluoro-4-Iodophenol(2713-28-2)
• EPA Substance Registry System: 2-Fluoro-4-Iodophenol(2713-28-2)

Safety Data

• Hazardous Substances Data: 2713-28-2(Hazardous Substances Data)

Usage

General Description

2-Fluoro-4-Iodophenol is a chemical compound with the molecular formula C6H4FIO. It is an aromatic compound with a phenol group and has both a fluorine and iodine atom attached to different positions on the phenol ring. 2-Fluoro-4-Iodophenol is used in organic synthesis and pharmaceutical research as a building block for creating more complex molecules. It is also used in the production of fine chemicals and as a reagent in chemical reactions. Due to its unique structure and properties, 2-Fluoro-4-Iodophenol has potential applications in fields such as medicinal chemistry and material science. However, it should be handled with care and under proper safety precautions due to its potentially hazardous nature.

InChI:InChI=1/C6H4FIO/c7-5-3-4(8)1-2-6(5)9/h1-3,9H

Upstream product

• 3824-21-3 (3-fluoro-4-methoxyphenyl) iodide 
• 367-12-4 2-fluorophenol 
• 366-99-4 3-fluoro-4-methoxyaniline 
• 1030828-91-1 2-fluoro-4-iodophenylacetate 

Downstream Products

• 366-97-2 (2-fluoro-4-iodo-phenoxy)-acetic acid 
• 1312312-61-0 2-fluoro-4-iodophenyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranoside 
• 1257107-60-0 (2-fluoro-4-iodo-phenoxy)-acetic acid ethyl ester 
• 1257107-68-8 (R)-2-[2-fluoro-4-[3-[[1-(4-fluoro-3-methoxy-phenyl)ethyl]amino]-propyl]phenoxy]acetic acid 
• 1257107-69-9 (R)-{2-Fluoro-4-[3-(1-naphthalen-1-yl-ethylamino)-propyl]-phenoxy}-acetic acid 
• 1312312-62-1 C₂₈H₂₈FNO₁₀ 
• 1312312-63-2 C₂₈H₂₇FN₂O₁₂ 
• 1312312-64-3 2-fluoro-4-(indol-1-yl)phenyl α-D-mannopyranoside 
• 56926-74-0 (E)-3-(3-fluoro-4-hydroxyphenyl)acrylic acid 
• 1505448-04-3 2-(8-(2-fluoro-4-iodophenoxy)oct-6-yn-1-yl)-2-methyl-1,3-dioxolane 
• 1610035-72-7 2-((2S,3S,4R)-1-(4-(((3,4-trans)-1-(5-chloro-2-methoxypyridin-4-yl)-3-methylpiperidin4-yl)oxy)-3-fluorophenyl)-4-methoxy-3-methylpyrrolidin-2-yl)acetic acid 
• 1610035-74-9 ((2R,3S,4R)-1-(4-(((3,4-trans)-1-(5-chloro-2-methoxypyridin-4-yl)-3-methylpiperidin-4-yl)oxy)-3-fluorophenyl)-4-methoxy-3-methylpyrrolidin-2-yl)methanol 
• 1610035-75-0 ((2R,3S,4R)-1-(4-(((3,4-trans)-1-(5-chloro-2-methoxypyridin-4-yl)-3-methylpiperidin-4-yl)oxy)-3-fluorophenyl)-4-methoxy-3-methylpyrrolidin-2-yl)methyl methanesulfonate 
• 1610035-76-1 2-((2S,3S,4R)-1-(4-(((3,4-trans)-1-(5-chloro-2-methoxypyridin-4-yl)-3-methylpiperidin-4-yl)oxy)-3-fluorophenyl)-4-methoxy-3-methylpyrrolidin-2-yl)acetonitrile 

Relevant articles and documents

TETRASUBSTITUTED ALKENE COMPOUNDS AND THEIR USE

Disclosed herein are compounds, or pharmaceutically acceptable salts thereof, and methods of using the compounds for treating breast cancer by administration to a subject in need thereof a therapeutically effective amount of the compounds or pharmaceutically acceptable salts thereof. The breast cancer may be an ER-positive breast cancer and/or the subject in need of treatment may express a mutant ER-α protein.

CALCIUM-SENSING RECEPTOR-ACTIVE COMPOUNDS

A compound of general formula I their use as calcium receptor-active compounds for the prophylaxis, treatment or amelioration of physiological disorders or diseases associated with disturbances of CaSR activity, such as hyperparathyroidism, pharmaceutical

NOVEL PHENYL-ISOXAZOL-3-OL DERIVATIVE

The present invention relates to a compound represented by formula (I), which has a GPR120 agonist action and thus is useful for treatment of diabetes mellitus or hyperlipidemia, or a pharmaceutically acceptable salt thereof. In the formula, (AA) represents a phenyl or the like, which may be substituted with a lower alkoxy group or the like; (BB) represents a divalent group or the like, derived by removal of two hydrogen atoms from a benzene which may be substituted with a halogen atom or the like; X represents a spacer having a main chain composed of 1-8 carbon atoms wherein 1-3 carbon atoms in the main chain may be substituted with an oxygen atom or the like; and Y represents a hydrogen atom or the like.